IBB Holdings Information

IBB is an equity ETF with a total of 265 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 8.35%, Gilead Sciences at 8.14%, Amgen at 7.85%, Regeneron Pharmaceuticals at 6.50%, and Alnylam Pharmaceuticals at 4.09%.

Total Holdings

265

Top 10 Percentage

47.65%

Asset Class

Equity

ETF Category

Health

Assets

8.53B

PE Ratio

23.95

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	VRTX	Vertex Pharmaceuticals Incorporated	8.35%	1,608,164
2	GILD	Gilead Sciences, Inc.	8.14%	5,541,272
3	AMGN	Amgen Inc.	7.85%	2,018,507
4	REGN	Regeneron Pharmaceuticals, Inc.	6.50%	753,669
5	ALNY	Alnylam Pharmaceuticals, Inc.	4.09%	966,467
6	INSM	Insmed Incorporated	2.97%	1,566,389
7	ARGX	argenx SE	2.84%	301,450
8	NTRA	Natera, Inc.	2.66%	978,220
9	ONC	BeOne Medicines AG	2.14%	538,540
10	BIIB	Biogen Inc.	2.11%	1,090,772
11	ILMN	Illumina, Inc.	1.84%	1,106,153
12	INCY	Incyte Corporation	1.81%	1,446,337
13	RVMD	Revolution Medicines, Inc.	1.74%	1,231,188
14	UTHR	United Therapeutics Corporation	1.69%	309,361
15	GMAB	Genmab A/S	1.39%	3,662,196
16	MRNA	Moderna, Inc.	1.27%	2,581,446
17	MEDP	Medpace Holdings, Inc.	1.21%	168,299
18	NBIX	Neurocrine Biosciences, Inc.	1.13%	723,035
19	BBIO	BridgeBio Pharma, Inc.	1.10%	1,225,514
20	IONS	Ionis Pharmaceuticals, Inc.	1.06%	1,183,105
21	EXEL	Exelixis, Inc.	1.00%	1,933,952
22	CRL	Charles River Laboratories International, Inc.	0.94%	362,309
23	TECH	Bio-Techne Corporation	0.93%	1,146,692
24	MDGL	Madrigal Pharmaceuticals, Inc.	0.91%	153,621
25	BMRN	BioMarin Pharmaceutical Inc.	0.91%	1,409,915

Showing 25 of 265 holdings

Subscribe to see the full list

Activate Now

As of Jan 16, 2026